FDA Inspection 1217077 — Southwest Transplant Alliance
The FDA completed an inspection of Southwest Transplant Alliance on August 22, 2023 in El Paso, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 22, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- El Paso, TX (United States)